Lipoid pneumonia: a preventable form of drug-induced lung injury

E Meltzer1, L Guranda, M Perelman

  • 1Department of Internal Medicine C, Sheba Medical Center, Tel Hashomer, Israel. emeltzer@post.tau.ac.il

Insights

Recurrent pneumonia was diagnosed as lipoid pneumonia in an elderly patient. Stopping the paraffin oil laxative improved symptoms, suggesting this common laxative may cause lung disease.

Area of Science:

  • Pulmonary Medicine
  • Toxicology

Background:

  • Lipoid pneumonia is a lung reaction to lipids, often underdiagnosed.
  • Paraffin oil laxatives are a common cause but their risks are not well-known.

Purpose of the Study:

  • To report a case of lipoid pneumonia caused by paraffin oil laxative.
  • To highlight the underdiagnosis and underreporting of lipoid pneumonia.
  • To suggest regulatory changes for paraffin oil products.

Main Methods:

  • Case report of an elderly patient with recurrent pneumonia.
  • Clinical assessment and diagnosis of lipoid pneumonia.
  • Monitoring patient's response to discontinuation of paraffin oil laxative.

Main Results:

  • The patient's recurrent pneumonia was diagnosed as lipoid pneumonia.
  • Discontinuation of the paraffin oil laxative resulted in clinical improvement.
  • Paraffin oil was identified as the likely causative agent.

Conclusions:

  • Paraffin oil laxatives can cause lipoid pneumonia.
  • Increased awareness and regulatory changes for paraffin oil are needed.
  • Lipoid pneumonia may be more common than currently recognized.

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...